Nine BC health researchers have been funded in MSFHR’s third Innovation to Commercialization (I2C) competition. Each will receive funding to advance their medical treatments, diagnostic tools and assistive technologies towards practical application to improve health outcomes and enrich the health innovation ecosystem in BC.
A team of BC Cancer researchers, with funding support from MSFHR, have uncovered the tricks the deadliest ovarian cancer uses to escape the immune system.
Forty-eight* exceptional young investigators will receive Trainee awards from the Michael Smith Foundation for Health Research to support post-doctoral study at BC institutions.
More than 23,000 British Columbians will be diagnosed with cancer this year, and one in three British Columbians will develop some form of cancer in their lifetime.